The store will not work correctly when cookies are disabled.
5-Benzyl-2,3-diphenyl-4H-pyrazolo[1,5-a]pyrimidin-7-one
ID: ALA3715763
PubChem CID: 2197558
Max Phase: Preclinical
Molecular Formula: C25H19N3O
Molecular Weight: 377.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1cc(Cc2ccccc2)[nH]c2c(-c3ccccc3)c(-c3ccccc3)nn12
Standard InChI: InChI=1S/C25H19N3O/c29-22-17-21(16-18-10-4-1-5-11-18)26-25-23(19-12-6-2-7-13-19)24(27-28(22)25)20-14-8-3-9-15-20/h1-15,17,26H,16H2
Standard InChI Key: BLVVIFDPFZHYLP-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9991 2.7132 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 -1.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6221 -3.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9838 -4.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9039 -5.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4624 -5.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1007 -3.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0896 0.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9234 1.2700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4199 1.1671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0791 -0.1803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2418 -1.4248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7453 -1.3220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 -2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9282 -3.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9331 -5.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6365 -5.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3350 -5.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3301 -3.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 4 1 0
5 1 1 0
1 2 1 0
2 3 2 0
3 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 2 0
3 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
7 12 1 0
8 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
11 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.45 | Molecular Weight (Monoisotopic): 377.1528 | AlogP: 4.95 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.16 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.37 | CX Basic pKa: 2.27 | CX LogP: 5.64 | CX LogD: 5.64 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.48 | Np Likeness Score: -0.74 |
References
1. (2012) Heterocyclic compounds for the inhibition of pask, |
2. (2012) Heterocyclic compounds for the inhibition of pask, |
3. (2017) Arf6 inhibitors and methods of synthesis and use thereof, |